What Prime Medicine, Inc.'s executives and directors are doing with their own shares, from SEC Form 3/4/5 filings — separating what the filings state (awards, withholding, disclosed plans) from what only the pattern of dates shows.
| 3 months | 12 months | |
|---|---|---|
| Open-market buys | 0 | 0 |
| Sells | 0 | 0 |
| Total trades | 0 | 0 |
| 3 months | 12 months | |
|---|---|---|
| Acquired | 0 | 0 |
| Disposed | 0 | 0 |
| Net activity | +0 | +0 |
View rich charts and dive into the patterns of specific insiders — who is accumulating, who is winding down, and which sale explanations the filings actually support.
| Insider | Relation | Date | Transaction | Shares | Price | Value | Shares held |
|---|---|---|---|---|---|---|---|
| Arch Venture Partners X, Llc | 10% owner | Aug 01 | Open-market buy · P | +3,030,300 | $3.30 | +$10M | 6,230,300 |
| Arch Venture Partners XII, Llc | 10% owner | Aug 01 | Open-market buy · P | +3,030,300 | $3.30 | +$10M | 6,230,300 |
| Nelsen Robert | Director | Aug 01 | Open-market buy · P | +3,030,300 | $3.30 | +$10M | 6,230,300 |
| Gv 2021 GP, L.l.c. | 10% owner | Aug 01 | Open-market buy · P | +1,500,000 | $3.30 | +$4.95M | 3,262,440 |
| Liu David R. | 10% owner | Jun 30 | Open-market buy · P | +21,000 | $2.52 | +$52.8K | 20,240,945 |
| Liu David R. | 10% owner | Jun 23 | Open-market buy · P | +21,000 | $2.16 | +$45.4K | 20,219,945 |
| Liu David R. | 10% owner | Jun 16 | Open-market buy · P | +21,000 | $1.49 | +$31.2K | 20,198,945 |
| Liu David R. | 10% owner | Jun 11 | Open-market buy · P | +21,000 | $1.60 | +$33.6K | 20,177,945 |
| Reine Allan | Chief Executive Officer | May 21 | Open-market buy · P | +125,000 | $1.18 | +$147K | 125,000 |
| Lee Ann L. | Chief Technical Officer | May 21 | Open-market buy · P | +100,000 | $1.13 | +$113K | 100,000 |
| Brudnick Richard | Chief Business Officer | May 20 | Open-market buy · P | +20,000 | $1.19 | +$23.8K | 20,000 |
| Gottesdiener Keith Michael | See Remarks | Oct 08 | Gift · G | +226,925 | — | — | 682,259 |
| Gottesdiener Keith Michael | See Remarks | Oct 08 | Gift · G | −226,925 | — | — | 50,241 |
| Gottesdiener Keith Michael | See Remarks | Jun 05 | Gift · G | +250,000 | — | — | 277,166 |
| Gottesdiener Keith Michael | See Remarks | Jun 05 | Gift · G | −250,000 | — | — | 2,310,837 |
| Arch Venture Partners X, Llc | 10% owner | Feb 15 | Open-market buy · P | +3,200,000 | $6.25 | +$20M | 3,200,000 |
| Nelsen Robert | Director | Feb 15 | Open-market buy · P | +3,200,000 | $6.25 | +$20M | 3,200,000 |
| Arch Venture Partners XII, Llc | 10% owner | Feb 15 | Open-market buy · P | +3,200,000 | $6.25 | +$20M | 3,200,000 |
| Gottesdiener Keith Michael | See Remarks | Nov 11 | Gift · G | −5,000 | — | — | 27,166 |
| Gottesdiener Keith Michael | See Remarks | Nov 11 | Gift · G | −7,500 | — | — | 2,560,837 |
Loading...